ANGO Financial Facts

Interest expense: -723K
Cost of sales: 43.07M
See Full Income Statement

INTANGIBLE ASSETS, less accumulated amortization: 162.34M
Cash and cash equivalents: 37.41M
See Full Balance Sheet

AngioDynamics (ANGO) Earnings

  |   Expand Research on ANGO
Next EPS Date 1/6/17 *Est. EPS Growth Rate +54.5% *Last Qtr.
Average EPS % Beat Rate +6.5% Revenue Growth Rate +5.3% *Last Qtr.
Average % Move 1-Wk after EPS +12.8% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
7/23/14 Q414 $0.18$0.12 +$0.06$94.1M$93.65M Details
7/16/15 Q415 $0.14$0.14 $0.00$90.9M$91.67M = Details
1/8/15 Q215 $0.17$0.15 +$0.02$92.1M$90.9M Details
4/9/15 Q315 $0.12$0.16 -$0.04$86.6M$89.8M Details
1/7/16 Q216 $0.14$0.14 $0.00$89.2M$88.67M = Details
7/13/16 Q416 $0.19$0.16 +$0.03$93.4M$88.41M = Details
1/9/14 Q214 $0.14$0.07 +$0.07$88.6M$87.54M N/A Details
1/3/13 Q213 $0.10$0.09 +$0.01$87M$87.4M = Details